KLHDC5, or Kelch Domain Containing 5, is part of the kelch-like family of proteins, which are recognized for their roles in various cellular processes, including ubiquitination, a critical pathway for protein degradation and turnover. As a component of the CUL3 E3 ubiquitin ligase complex, KLHDC5 functions to identify and bind specific substrate proteins, facilitating their ubiquitination and subsequent degradation by the proteasome. This activity is essential for regulating protein homeostasis within cells, which influences numerous cellular functions such as cell cycle control, signal transduction, and response to stress. The proper function of KLHDC5 ensures that proteins which are damaged, misfolded, or otherwise no longer needed are efficiently degraded, thus maintaining cellular health and preventing the accumulation of protein aggregates that can lead to cell dysfunction and disease.
The activation of KLHDC5 is a finely tuned process that involves several regulatory mechanisms. At the most fundamental level, the interaction of KLHDC5 with the CUL3 protein is crucial for its function in the ubiquitination pathway. This interaction is typically facilitated by the kelch repeats of KLHDC5, which form a beta-propeller structure capable of binding to various substrates and possibly to CUL3 itself. The activation of KLHDC5 may be influenced by post-translational modifications that affect its conformation and binding capabilities. For instance, phosphorylation at specific sites on KLHDC5 could enhance its binding affinity for the E3 ligase complex or for its substrates, effectively increasing its ubiquitination activity. Additionally, the expression levels of KLHDC5 can be regulated at the transcriptional level in response to cellular cues such as oxidative stress or DNA damage, which require a rapid response to manage damaged or dysfunctional proteins.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor. By halting proteasomal degradation, proteins like KLHDC5 might see altered stability or activity due to shifted protein turnover dynamics. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, leading to increased cAMP. cAMP can modulate various cellular processes which may indirectly affect KLHDC5. | ||||||
Palmitoleic acid | 373-49-9 | sc-205424 sc-205424A sc-205424B sc-205424C sc-205424D | 100 mg 500 mg 1 g 5 g 10 g | $33.00 $135.00 $238.00 $1039.00 $1907.00 | 4 | |
Involved in lipid signaling. Changes in lipid signaling can influence membrane-associated proteins or cellular dynamics that may affect KLHDC5. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Protein phosphatase inhibitor, which can affect protein phosphorylation dynamics and potentially influence KLHDC5. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog. By modulating cAMP-dependent pathways, it can have indirect effects on KLHDC5 dynamics. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum kinase inhibitor. It affects multiple kinases which can indirectly influence KLHDC5. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Calcium ionophore that alters intracellular calcium levels, leading to various cellular responses that might modulate KLHDC5. | ||||||